Credit Suisse Upgrades Humana (HUM) to Outperform; Trump Black Swan Event
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Humana (HUM) PT Raised to $230 at Jefferies; 'Upside Still trumps Downside'
November 15, 2016 6:55 AM ESTJefferies analyst David Windley reiterated a Buy rating and boosted his price target on Humana (NYSE: HUM) to $230.00 (from $206.00) following meetings with management. The analyst said upside trumps downside.
Windley commented, "Our meetings with Humana's CFO Brian Kane explored organic improvement in the business to status of the AET deal to Trump election implications. Improved '16 EPS, a... More
